Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.38 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.37 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | NPY4R | P50391 | 8/20 | 0.35 |
| ▸ | NPY1R | P25929 | 5/20 | 0.35 |
| ▸ | NPY2R | P49146 | 3/20 | 0.35 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.35 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.35 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.35 |
| ▸ | OTC | P00480 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL93472 | 1.00 | FOLH1 (0.38) | FOLH1ITGB3ITGA2BALOX15C3AR1 | |
| SCHEMBL17769024 | 1.00 | FOLH1 (0.38) | FOLH1ITGB3ITGA2BALOX15C3AR1 | |
| SCHEMBL162756 | 1.00 | FOLH1 (0.38) | FOLH1ITGB3ITGA2BALOX15C3AR1 | |
| Hydrochloric Acid SCHEMBL1578565 | 0.98 | FOLH1 (0.37) | FOLH1ITGB3ITGA2BALOX15C3AR1 | |
| Hydrochloric Acid SCHEMBL7367067 | 0.98 | FOLH1 (0.37) | FOLH1ITGB3ITGA2BALOX15C3AR1 | |
| Hydrochloric Acid SCHEMBL974818 | 0.98 | FOLH1 (0.37) | FOLH1ITGB3ITGA2BALOX15C3AR1 | |
| Acetic Acid SCHEMBL2170653 | 0.97 | FOLH1 (0.39) | FOLH1ITGB3ITGA2BALOX15C3AR1 | |
| Acetic Acid SCHEMBL160844 | 0.97 | FOLH1 (0.39) | FOLH1ITGB3ITGA2BALOX15C3AR1 | |
| Acetic Acid SCHEMBL1551710 | 0.97 | FOLH1 (0.39) | FOLH1ITGB3ITGA2BALOX15C3AR1 | |
| SCHEMBL8663352 | 0.95 | FOLH1 (0.43) | FOLH1ALOX15MEN1KMT2ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8392 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139257-A1 | PLIN1 RNAi INTERFERENCE AGENTS | ELI LILLY AND CO (US) | 2026-05-21 | — | — | US | claimed |
| EP-4743120-A1 | MOLECULAR DEGRADERS FOR THE TREATMENT OF IGA NEPHROPATHY | Biohaven Therapeutics Ltd. (VG) | 2026-05-20 | — | — | EP | claimed |
| EP-4745237-A1 | RNAI AGENT FOR INHIBITING EXPRESSION OF KETOHEXOKINASE AND USE THEREOF | YUN HO BIO CO., LTD (CN) | 2026-05-20 | — | — | EP | claimed |
| US-20260116921-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | PROTAGONIST THERAPEUTICS INC (US) | 2026-04-30 | — | — | US | claimed |
| EP-4720086-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | Zealand Pharma A/S (DK) | 2026-04-08 | — | — | EP | claimed |
| EP-4720087-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | Zealand Pharma A/S (DK) | 2026-04-08 | — | — | EP | claimed |
| EP-3570864-B1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | PROTAGONIST THERAPEUTICS INC (US) | 2026-02-18 | — | — | EP | claimed |
| US-20250382344-A1 | Soluble GLP1/GIP/NPY2 Receptor Triple Agonists | BOEHRINGER INGELHEIM INT GMH (DE) | 2025-12-18 | — | — | US | claimed |
| EP-4658374-A1 | METHODS FOR PREPARING CRYSTALLINE PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | Janssen Pharmaceutica NV (BE) | 2025-12-10 | — | — | EP | claimed |
| EP-4648849-A1 | NMU RECEPTOR 2 AGONISTS | Boehringer Ingelheim International GmbH (DE) | 2025-11-19 | — | — | EP | claimed |
| WO-1993005780-A1 | AMINO ACIDS CONTAINING PARENTERAL FORMULATIONS FOR THE TREATMENT OF HYPOTENSION AND RELATED PATHOLOGIES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1993-04-01 | — | — | WO | claimed |
| WO-1993000893-A1 | NITRIC OXIDE SYNTHESIS INHIBITORS FOR POTENTIATING THE ACTION OF PRESSOR AGENTS IN CERTAIN HYPOTENSIVE PATIENTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1993-01-21 | — | — | WO | claimed |
| WO-1993000108-A1 | NOVEL INHIBITORS OF PLATELET AGGREGATION | CORVAS INTERNATIONAL, INC. (US) | 1993-01-07 | — | — | WO | claimed |
| WO-1992017504-A1 | MACROPHAGE CYTOTOXIN COMPOSITIONS AND METHODS OF PREPARATION | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1992-10-15 | — | — | WO | claimed |
| CN-1054773-A | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORP (US) | 1991-09-25 | — | — | CN | claimed |
| WO-1991004024-A1 | ARGININE ANTAGONISTS FOR INHIBITION OF SYSTEMIC HYPOTENSION ASSOCIATED WITH NITRIC OXIDE PRODUCTION OR ENDOTHELIAL DERIVED RELAXING FACTOR | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1991-04-04 | — | — | WO | claimed |
| EP-0383472-A2 | Insulin analogs | ELI LILLY AND COMPANY (US) | 1990-08-22 | — | — | EP | claimed |
| CN-1044820-A | insulin analogues | LILLY CO ELI (US) | 1990-08-22 | — | — | CN | claimed |
| EP-0269299-A2 | Atrial peptides | NOVO NORDISK A/S (DK) | 1988-06-01 | — | — | EP | claimed |
| WO-1988003537-A1 | NOVEL PEPTIDES | NOVO INDUSTRI A/S (DK) | 1988-05-19 | — | — | WO | claimed |